Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group

Centro de Coordinación de Alertas y Emergencias Sanitarias. Dirección General de Salud Pública. Ministerio de Sanidad. Instituto de Salud Carlos III. Procedimiento de actuación frente a casos de infección por el nuevo coronavirus (2019-nCoV) [updated 6 Feb 2020]. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Procedimiento2019-nCoV.pdf. WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 30 January 2020. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-secondmeeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novelcoronavirus-(2019-ncov). Cai, 2020, First case of 2019 novel coronavirus infection in children in Shanghai, Zhonghua Er Ke Za Zhi, 58, E002 Li, 2020, Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia, N Engl J Med, 10.1056/NEJMoa2001316 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 WHO. Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance. WHO/nCoV/Clinical/2020.2. Chen, 2020, Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus, World J Pediatr, 10.1007/s12519-020-00345-5 Shen, 2020, Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement, World J Pediatr Lee, 2014, Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age, Pediatr Infect Dis J, 33, 814, 10.1097/INF.0000000000000292 Jean, 2013, Severity and outcome associated with human coronavirus OC43 infections among children, Pediatr Infect Dis J, 32, 325, 10.1097/INF.0b013e3182812787 Konca, 2017, The first infant death associated with human coronavirus NL63 infection, Pediatr Infect Dis J, 36, 231, 10.1097/INF.0000000000001390 de Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol, 14, 523, 10.1038/nrmicro.2016.81 Zhu, 2020, Coronavirus Investigating, and Research Team. A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 10.1056/NEJMoa2001017 Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 10.1016/S0140-6736(20)30154-9 Rothe, 2020, Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany, N Engl J Med, 10.1056/NEJMc2001468 Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. www.thelancet.com Published online February 12, 2020 https://doi.org/10.1016/S0140-6736(20)30360-3. Chu, 2020, Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia, Clin Chem, 10.1093/clinchem/hvaa029 MinWei M.D., Yuan J., Liu Y., Fu T., Yu X., Zhang Z.J. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA Published online February 14. 2020, https://doi.org/10.1001/jama.2020.2131. Khemani, 2015, Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference, Pediatr Crit Care Med, 16, S23, 10.1097/PCC.0000000000000432 Goldstein, 2005, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics, Pediatr Crit Care Med, 6, 2, 10.1097/01.PCC.0000149131.72248.E6 Davis, 2017, American College of Critical Care Medicine Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock, Crit Care Med, 45, 1061, 10.1097/CCM.0000000000002425 WHO. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. WHO/nCov/IPC_HomeCare/2020.1. Khemani, 2015, Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference, Pediatr Crit Care Med, 16, S23, 10.1097/PCC.0000000000000432 Rimensberger, 2015, Ventilatory support in children with pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference, Pediatr Crit Care Med, 16, S51, 10.1097/PCC.0000000000000433 Fan, 2017, An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical ventilation in adult patients with acute respiratory distress syndrome, Am J Respir Crit Care Med, 195, 1253, 10.1164/rccm.201703-0548ST Rhodes, 2017, Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016, Intensive Care Med, 43, 304, 10.1007/s00134-017-4683-6 Weiss, 2020, Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children, Crit Care Med, 21, e52, 10.1097/PCC.0000000000002198 Rodrigo, 2016, Corticosteroids as adjunctive therapy in the treatment of influenza, Cochrane Database Syst Rev, 3, CD010406 Delaney, 2016, The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness, Crit Care, 20, 75, 10.1186/s13054-016-1230-8 Arabi, 2018, Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome, Am J Respir Crit Care Med, 197, 757, 10.1164/rccm.201706-1172OC Lu, 2020, Drug treatment options for the 2019-new coronavirus (2019-nCoV), BioScience Trends, 10.5582/bst.2020.01020 Chu, 2004, HKU/UCH SARS Study Group. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 Sheahan, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERSCoV, Nat Commun, 11, 222, 10.1038/s41467-019-13940-6 Agostini, 2018, Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease, mBio, 9, 10.1128/mBio.00221-18 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N Engl J Med, 10.1056/NEJMoa2001191 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res Richardson, 2020, Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet, 395, e30, 10.1016/S0140-6736(20)30304-4